Propranolol and polythiazide in treatment of hypertension.
D000328:Adult; D001741:Black or African American; D001794:Blood Pressure / Q000187:drug effects; D001986:Bronchial Spasm / Q000139:chemically induced; D004357:Drug Synergism; D005260:Female; D006212:Hallucinations / Q000139:chemically induced; D006801:Humans; D006973:Hypertension / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D011139:Polythiazide / Q000009:adverse effects / Q000627:therapeutic use*; D011433:Propranolol / Q000009:adverse effects / Q000627:therapeutic use*; D011674:Pulse / Q000187:drug effects; D044469:Racial Groups; D012893:Sleep Wake Disorders / Q000139:chemically induced; D013375:Substance Withdrawal Syndrome; D014717:Vertigo / Q000139:chemically induced
D011139:Polythiazide; D011433:Propranolol